Literature DB >> 20018732

Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway.

Shang-Yi Tsai1, Teruo Hayashi, Brandon K Harvey, Yun Wang, Wells W Wu, Rong-Fong Shen, Yongqing Zhang, Kevin G Becker, Barry J Hoffer, Tsung-Ping Su.   

Abstract

Sigma-1 receptors (Sig-1Rs) are endoplasmic reticulum (ER)-resident proteins known to be involved in learning and memory. Dendritic spines in hippocampal neurons play important roles in neuroplasticity and learning and memory. This study tested the hypothesis that Sig-1Rs might regulate denritic spine formation in hippocampal neurons and examined potential mechanisms therein. In rat hippocampal primary neurons, the knockdown of Sig-1Rs by siRNAs causes a deficit in the formation of dendritic spines that is unrelated to ER Ca(2+) signaling or apoptosis, but correlates with the mitochondrial permeability transition and cytochrome c release, followed by caspase-3 activation, Tiam1 cleavage, and a reduction in Rac1.GTP. Sig-1R-knockdown neurons contain higher levels of free radicals when compared to control neurons. The activation of superoxide dismutase or the application of the hydroxyl-free radical scavenger N-acetyl cysteine (NAC) to the Sig-1R-knockdown neurons rescues dendritic spines and mitochondria from the deficits caused by Sig-1R siRNA. Further, the caspase-3-resistant TIAM1 construct C1199DN, a stable guanine exchange factor able to constitutively activate Rac1 in the form of Rac1.GTP, also reverses the siRNA-induced dendritic spine deficits. In addition, constitutively active Rac1.GTP reverses this deficit. These results implicate Sig-1Rs as endogenous regulators of hippopcampal dendritic spine formation and suggest a free radical-sensitive ER-mitochondrion-Rac1.GTP pathway in the regulation of dendritic spine formation in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018732      PMCID: PMC2792161          DOI: 10.1073/pnas.0909089106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.

Authors:  S H Snyder; B L Largent
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1989       Impact factor: 2.198

2.  Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat.

Authors:  A M Graybiel; M J Besson; E Weber
Journal:  J Neurosci       Date:  1989-01       Impact factor: 6.167

3.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

Review 4.  Making the connection: cytoskeletal rearrangements during growth cone guidance.

Authors:  E Tanaka; J Sabry
Journal:  Cell       Date:  1995-10-20       Impact factor: 41.582

5.  Structural-functional correlates of neuroprotection in the aging rabbit by a calcium channel blocker. Nimodipine reverses neocortical dendritic atrophy and improves memory retention.

Authors:  R F Mervis; N Kuntz; D Burton; R Dvorak; R Tandon; L Hoover; M S Wood; P R Solomon
Journal:  Ann N Y Acad Sci       Date:  1995-09-15       Impact factor: 5.691

6.  Inhibition of selenite-catalyzed superoxide generation and formation of elemental selenium (Se(o)) by copper, zinc, and aurintricarboxylic acid (ATA).

Authors:  R L Davis; J E Spallholz
Journal:  Biochem Pharmacol       Date:  1996-04-26       Impact factor: 5.858

7.  Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-related mechanism.

Authors:  P Bouchard; T Maurice; S St-Pierre; A Privat; R Quirion
Journal:  Eur J Neurosci       Date:  1997-10       Impact factor: 3.386

8.  Actin cleavage by CPP-32/apopain during the development of apoptosis.

Authors:  T Mashima; M Naito; K Noguchi; D K Miller; D W Nicholson; T Tsuruo
Journal:  Oncogene       Date:  1997-03-06       Impact factor: 9.867

Review 9.  Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands.

Authors:  T Maurice; B P Lockhart
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-01       Impact factor: 5.067

10.  The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.

Authors:  Dominique Fontanilla; Molly Johannessen; Abdol R Hajipour; Nicholas V Cozzi; Meyer B Jackson; Arnold E Ruoho
Journal:  Science       Date:  2009-02-13       Impact factor: 47.728

View more
  57 in total

1.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

Review 2.  The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.

Authors:  Tsung-Ping Su; Tzu-Chieh Su; Yoki Nakamura; Shang-Yi Tsai
Journal:  Trends Pharmacol Sci       Date:  2016-02-09       Impact factor: 14.819

Review 3.  Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Shang-Yi Tsai; Tomohisa Mori; Michiko Fujimoto; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2011-03-05       Impact factor: 6.902

Review 4.  Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.

Authors:  Shang-Yi A Tsai; Michael J Pokrass; Neal R Klauer; Nicole E De Credico; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2014-10-21       Impact factor: 6.902

5.  The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.

Authors:  Daniel Ryskamp; Jun Wu; Michal Geva; Rebecca Kusko; Iris Grossman; Michael Hayden; Ilya Bezprozvanny
Journal:  Neurobiol Dis       Date:  2016-11-03       Impact factor: 5.996

Review 6.  Sigma-1 Receptors Fine-Tune the Neuronal Networks.

Authors:  Shang-Yi Anne Tsai; Tsung-Ping Su
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 7.  Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.

Authors:  Linda Nguyen; Brandon P Lucke-Wold; Shona Mookerjee; Nidhi Kaushal; Rae R Matsumoto
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

8.  The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements.

Authors:  Arindam Pal; Dominique Fontanilla; Anupama Gopalakrishnan; Young-Kee Chae; John L Markley; Arnold E Ruoho
Journal:  Eur J Pharmacol       Date:  2012-02-22       Impact factor: 4.432

Review 9.  A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.

Authors:  Ede Frecska; Attila Szabo; Michael J Winkelman; Luis E Luna; Dennis J McKenna
Journal:  J Neural Transm (Vienna)       Date:  2013-04-26       Impact factor: 3.575

Review 10.  A role for sigma receptors in stimulant self-administration and addiction.

Authors:  Jonathan L Katz; Weimin C Hong; Takato Hiranita; Tsung-Ping Su
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.